Yahoo Finance highlighted Pictor’s announcement on our multiplex proteomics approach—spotlighting PictHealth™/PictVet™ developments that support faster, cost-minded laboratory workflows for earlier, more reliable detection of Mycoplasma bovis in cattle. The coverage underscores our momentum as we expand U.S. operations and co-develop practical panels with partners.
Learn More
Clinical Lab Products covered Pictor’s successful completion of a convertible note round, led by existing investors, to support its U.S. expansion and advance commercialization of its PictArray™ multiplex proteomics platform. The funding will help accelerate partner-driven panel development across human and animal health, while expanding operations from the company’s new Carlsbad, California headquarters
Learn More
Pictor has announced new funding to support its U.S. growth and further develop its partner-informed proteomics solutions. This investment strengthens Pictor’s ability to expand operations, enhance its innovative platform, and deliver high-performance, cost-efficient diagnostic solutions to healthcare and research partners.
Learn More
On the Diagnosing Dx podcast, Pictor Chief Commercial Officer Janine McMurdie—drawing on leadership roles at Amgen and Ion Torrent—explores why proteomics is emerging as the next wave in diagnostics. She details how Pictor’s fast, flexible, and affordable platform puts patients first, navigates an evolving regulatory landscape, and leverages optimism to accelerate a science‑led future of precision health. Tune in on YouTube, Spotify, or Apple Podcasts to hear the full conversation.
Learn More
In David Meltzer’s recent LinkedIn Live session (watch from 13:42), CEO Jamie Platt contrasts genomics with proteomics, explains why real‑time protein insights are the next frontier in precision health, and reflects on a career of billion‑dollar exits and purpose‑built teams—reinforcing Pictor’s momentum to deliver transformative global diagnostics.
Learn More
The July issue of the Carlsbad Business Journal features Pictor’s Carlsbad lab opening on its front page, spotlighting a pivotal milestone in our U.S. expansion and drive to advance proteomics‑powered diagnostics. The coverage, made possible through the support of the Carlsbad Chamber of Commerce, underscores our commitment to grow alongside the region’s vibrant life‑sciences community.
Learn More
Pictor celebrates senior leader Kate Rhodes’s inclusion in the Carlsbad Chamber of Commerce’s “50 Over 50 – Special Edition,” which honors professionals who continue to shape industry and community. The recognition highlights Kate’s decades‑long leadership, operational excellence, and lasting impact on both Pictor’s growth and the broader San Diego life‑sciences ecosystem.
Learn More
On the June 3, 2025 episode of Tacos & Tech, host Neal Bloom speaks with Pictor CEO Jamie Gibson about how real‑time protein diagnostics are changing healthcare. The conversation covers the shift from DNA‑based tests to fast, accessible proteomics, Pictor’s move to San Diego, and the leadership lessons driving the company’s mission to make diagnostics quicker, cheaper, and more personal.
Learn More
The San Diego Business Journal spotlighted Pictor’s non-invasive, saliva-based proteomics technology—capable of delivering results in just four hours. CEO Jamie Platt discussed securing $5M in seed funding, plans to raise a $30M Series A, and a partnership-driven revenue model aimed at accelerating affordable, high-throughput testing for both pharma and clinical labs across the United States.
Learn MoreClinical Lab Products featured Pictor’s establishment of its U.S. headquarters in San Diego, noting this pivotal move to scale operations across North America. The coverage underscores our accelerating growth strategy and invites industry partners and investors to join upcoming ribbon‑cutting and executive sessions as we advance accessible proteomics solutions.
Learn MoreYahoo Finance covered our new Carlsbad headquarters, $5 M seed funding, and plans to scale low‑cost, high‑throughput multiplex proteomics testing—capitalizing on a recent court decision that keeps lab‑developed tests under CLIA oversight and clears the path for rapid U.S. expansion.
Learn More
Get in touch with us to discuss partnerships, investment opportunities, or learn more about our platform.
For support, requests or inquiries info@PictorDx.com
